The polycystic ovary syndrome is the most common endocrinological disorder of reproductive age women with a prevalence of 5 to 8 %. The most common diagnostic criteria used for polycystic ovary syndrome are oligo- or an-ovulation, clinical and/ or biochemical signs of hyperandrogenism and polycystic ovaries. Hyperandrogenism results in increased estrogen levels and lack of cyclic progesterone due to anovulation and persistent stimulation of the endometrium may lead to endometrial hyperplasia or adenocarcinoma development. In this mini review, we aimed to evaluate the possible relationship between polycystic ovary syndrome and endometrial cancer.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Tokmak, A., Kokanali, M. K., Guzel, A. I., Kara, A., Topcu, H. O., & Cavkaytar, S. (2014). Polycystic ovary syndrome and risk of endometrial cancer: A mini-review. Asian Pacific Journal of Cancer Prevention. Asian Pacific Organization for Cancer Prevention. https://doi.org/10.7314/APJCP.2014.15.17.7011